Our Publications

Click on a year to expand publications for that year.

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.

Authors Casey G, Lindor NM, Papadopoulos N, et al.
Citation JAMA. 2005 Feb 16;293(7):799-809.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15713769/
PMCID PMC2933041
Environmental risk factors and colorectal neoplasia: Recent developments.

Authors Chia V, Newcomb PA.
Citation Current Colorectal Cancer Reports. 2005;1(2):67-72.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/NA/
PMCID NA
Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry.

Authors Cotterchio M, Manno M, Klar N, et al.
Citation Cancer Causes Control. 2005 Sep;16(7):865-75.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/16132797/
PMCID NA
Association between colonic screening, subject characteristics, and stage of colorectal cancer.

Authors Fazio L, Cotterchio M, Manno M, et al.
Citation Am J Gastroenterol. 2005 Nov;100(11):2531-9.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/16279911/
PMCID NA
Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.

Authors Gill S, Lindor NM, Burgart LJ, et al.
Citation Clin Cancer Res. 2005 Sep 15;11(18):6466-71.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/16166421/
PMCID NA
Identifying target populations for screening or not screening using logic regression.

Authors Janes H, Pepe M, Kooperberg C.
Citation Stat Med. 2005 May 15;24(9):1321-38.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15568185/
PMCID NA
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial Colorectal Cancer Type X.

Authors Lindor NM, Rabe K, Petersen GM, et al.
Citation JAMA. 2005 Apr 27;293(16):1979-85.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15855431/
PMCID PMC2933042
Reasons given by relatives of colorectal cancer patients for not undergoing screening.

Authors Madlensky L, Esplen MJ, Goel V.
Citation Prev Med. 2004 Oct;39(4):643-8.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15351528/
PMCID NA
No evidence of an association of JC virus and colon neoplasia.

Authors Newcomb PA, Bush AC, Stoner GL, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):662-6.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15066935/
PMCID NA
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Authors Pepe MS, Janes H, Longton G, et al.
Citation Am J Epidemiol. 2004 May 1;159(9):882-90.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15105181/
PMCID NA
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors Umar A, Boland CR, Terdiman JP, et al.
Citation J Natl Cancer Inst. 2004 Feb 18;96(4):261-8.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/14970275/
PMCID PMC2933058
MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps.

Authors Wang L, Baudhuin LM, Boardman LA, et al.
Citation Gastroenterology. 2004 Jul;127(1):9-16. Erratum in: Gastroenterology. 2004 Nov;127(5):1651.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15236166/
PMCID NA
Evidence for an association between JC virus and colorectal neoplasia.

Authors Boland CR, Bigler J, Newcomb PA, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2285-6; author reply 2286.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15598796/
PMCID NA
Association between biallelic and monoallelic germline MYH mutations and colorectal cancer risk.

Authors Croitoru ME, Cleary SP, Di Nicola N, et al.
Citation J Natl Cancer Inst. 2004;96(21):1631-4.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15523092/
PMCID NA
The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval.

Authors Doria-Rose VP, Levin TR, Selby JV, et al.
Citation Gastroenterology. 2004; 127:714-722.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15362026/
PMCID NA
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.

Authors Kambara T, Simms LA, Whitehall VL, et al.
Citation Gut. 2004 Aug;53(8):1137-44.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15247181/
PMCID PMC1774130
Role of inherited defects of MYH in the development of sporadic colorectal cancer.

Authors Kambara T, Whitehall VL, Spring KJ, et al.
Citation Genes Chromosomes Cancer. 2004 May;40(1):1-9.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15034862/
PMCID NA
Colorectal tumour microsatellite instability test results: perspectives from patients.

Authors Lindor NM, Sloan J, Goldberg R, et al.
Citation Hered Cancer Clin Pract. 2004 May 15;2(2):69-75.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/20233473/
PMCID PMC2839997
Recognition of genetic syndromes in families with suspected hereditary colon cancer syndromes.

Authors Lindor NM.
Citation Clin Gastroenterol Hepatol. 2004 May;2(5):366-75.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/15118973/
PMCID NA
The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing.

Authors Esplen MJ, Urquhart C, Butler K, et al.
Citation J Psychosom Res. 2003 Nov;55(5):427-35.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/14581097/
PMCID NA
The APC E1317Q variant in adenomatous polyps and colorectal cancers.

Authors Hahnloser D, Peterson GM, Rabe K, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1023-8.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/14578138/
PMCID NA
Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age.

Authors Kakar S, Burgart LJ, Thibodeau SN, et al.
Citation Cancer. 2003 Mar 15;97(6):1421-7.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/12627505/
PMCID NA
Relatives of colorectal cancer patients: factors associated with screening behavior.

Authors Madlensky L, Esplen MJ, Gallinger S, et al.
Citation Am J Prev Med. 2003 Oct;25(3):187-94.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/14507524/
PMCID NA
A comparison of self-reported colorectal cancer screening with medical records.

Authors Madlensky L, McLaughlin J, Goel V.
Citation Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):656-9.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/12869407/
PMCID NA
Selection bias in the assessment of gene-environment interaction in case-control studies.

Authors Morimoto LM, White E, Newcomb PA.
Citation Am J Epidemiol. 2003 Aug 1;158(3):259-63.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/12882948/
PMCID NA
Agreement between proxy- and case-reported information obtained using the self-administered Ontario Familial Colon Cancer Registry epidemiologic questionnaire.

Authors Nadalin V, Cotterchio M, McKeown-Eyssen G.
Citation Chronic Dis Can. 2003 Winter;24(1):1-8.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/12757630/
PMCID NA
Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence.

Authors Newcomb PA, Storer B, Morimoto LM, et al.
Citation J Natl Cancer Inst. 2003 Apr 16;95(8):622-5.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/12697855/
PMCID NA
Attitudes towards genetic screening for predisposition to colon cancer among cancer patients, their relatives, and members of the community Results of focus group interviews.

Authors Ramsey SD, Wilson S, Spencer A, et al.
Citation Community Genet. 2003;6(1):29-36.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/12748436/
PMCID NA
Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study.

Authors Wright FC, Law CH, Last L, et al.
Citation Ann Surg Oncol. 2003 Oct;10(8):903-9.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/14527909/
PMCID NA
Validation of family history data in cancer family registries.

Authors Ziogas A, Anton-Culver H.
Citation Am J Prev Med. 2003 Feb;24(2):190-8.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/12568826/
PMCID NA
A population-based study of the extent of surgical resection of potentially curable colon cancer.

Authors Easson AM, Cotterchio M, Crosby JA, et al.
Citation Ann Surg Oncol. 2002 May;9(4):380-7.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/11986190/
PMCID NA
Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability.

Authors Jass JR, Walsh MD, Barker M, et al.
Citation Eur J Cancer. 2002 May;38(7):858-66.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/11978509/
PMCID NA
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.

Authors Lindor NM, Burgart LJ, Leontovich O, et al.
Citation J Clin Oncol. 2002 Feb 15;20(4):1043-8.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/11844828/
PMCID NA
Ascertainment bias in family-based case-control studies.

Authors Siegmund KD, Langholz B.
Citation Am J Epidemiol. 2002 May 1;155(9):875-80.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/11978593/
PMCID NA
Mutation searching in colorectal cancer studies: experience with a denaturing high pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genes.

Authors Young J, Barker M, Fraser L, et al.
Citation Pathology. 2002 Dec;34(6):529-33.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/12555990/
PMCID NA
Validity of proxy reports obtained using the Ontario Familial Colon Cancer Registry epidemiologic questionnaire.

Authors Nadalin V, Cotterchio M, McKeown-Eyssen G, et al.
Citation Am J Epidemiol. 2001;153:S88.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/NA/
PMCID NA
Stratified case sampling and the use of family controls.

Authors Siegmund KD, Langholz B.
Citation Genet Epidemiol. 2001 Apr;20(3):316-27.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/11255241/
PMCID NA
HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers.

Authors Young J, Biden KG, Simms LA, et al.
Citation Proc Natl Acad Sci USA. 2001 Jan 2;98(1):265-70.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/11120884/
PMCID PMC14579
Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.

Authors Young J, Simms LA, Biden KG, et al.
Citation Am J Pathol. 2001 Dec;159(6):2107-16.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/11733361/
PMCID PMC1850604
Ontario familial colon cancer registry: methods and first-year response rates.

Authors Cotterchio M, McKeown-Eyssen G, Sutherland H, et al.
Citation Chronic Dis Can. 2000;21(2):81-6.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/11007659/
PMCID NA
Study-design issues in the development of the University of Southern California Consortium’s Colorectal Cancer Family Registry.

Authors Haile RW, Siegmund KD, Gauderman WJ.
Citation J Natl Cancer Inst Monogr. 1999;(26):89-93.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/10854491/
PMCID NA
Combined influence of genetic and dietary factors on colorectal cancer incidence in Japanese Americans.

Authors Le Marchand L.
Citation J Natl Cancer Inst Monogr. 1999;(26):101-5.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/10854493/
PMCID NA
Innovative study designs and analytic approaches to the genetic epidemiology of cancer.

Authors Seminara D, ed.
Citation J Natl Cancer Inst Monogr. 1999;(26):1-105.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/NA/
PMCID NA
Multistage sampling for disease family registries.

Authors Siegmund KD, Whittemore AS, Thomas DC.
Citation J Natl Cancer Inst Monogr. 1999;(26):43-8.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/10854485/
PMCID NA

2007

2006

2005

2004

2003

2002

2001

2000

1999

Click on a year to expand publications for that year.

Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.

Environmental risk factors and colorectal neoplasia: Recent developments.

Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry.

Association between colonic screening, subject characteristics, and stage of colorectal cancer.

Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.

Identifying target populations for screening or not screening using logic regression.

Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial Colorectal Cancer Type X.

Reasons given by relatives of colorectal cancer patients for not undergoing screening.

No evidence of an association of JC virus and colon neoplasia.

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps.

Evidence for an association between JC virus and colorectal neoplasia.

Association between biallelic and monoallelic germline MYH mutations and colorectal cancer risk.

The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval.

BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.

Role of inherited defects of MYH in the development of sporadic colorectal cancer.

Colorectal tumour microsatellite instability test results: perspectives from patients.

Recognition of genetic syndromes in families with suspected hereditary colon cancer syndromes.

The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing.

The APC E1317Q variant in adenomatous polyps and colorectal cancers.

Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age.

Relatives of colorectal cancer patients: factors associated with screening behavior.

A comparison of self-reported colorectal cancer screening with medical records.

Selection bias in the assessment of gene-environment interaction in case-control studies.

Agreement between proxy- and case-reported information obtained using the self-administered Ontario Familial Colon Cancer Registry epidemiologic questionnaire.

Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence.

Attitudes towards genetic screening for predisposition to colon cancer among cancer patients, their relatives, and members of the community Results of focus group interviews.

Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study.

Validation of family history data in cancer family registries.

A population-based study of the extent of surgical resection of potentially curable colon cancer.

Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability.

Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.

Ascertainment bias in family-based case-control studies.

Mutation searching in colorectal cancer studies: experience with a denaturing high pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genes.

Validity of proxy reports obtained using the Ontario Familial Colon Cancer Registry epidemiologic questionnaire.

Stratified case sampling and the use of family controls.

HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers.

Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.

Ontario familial colon cancer registry: methods and first-year response rates.

Study-design issues in the development of the University of Southern California Consortium’s Colorectal Cancer Family Registry.

Combined influence of genetic and dietary factors on colorectal cancer incidence in Japanese Americans.

Innovative study designs and analytic approaches to the genetic epidemiology of cancer.

Multistage sampling for disease family registries.